Jon P. Otterstatter
Eagan-based Preventice Solutions is a digital health company that makes BodyGuardian, a wearable prescription-only medical device connected to a cloud-based infrastructure, which allows doctors to remotely track patients with cardiac arrhythmias.
What sets the tech apart is that doctors can track a patient’s heart from four different perspectives: short-term, long-term, cardiac event, and mobile cardiac telemetry. “That’s a very unique capability: a four-in-one monitor,” CEO Jon Otterstatter says.
Preventice is no startup. Founded in 2007, the company now has approximately 1,000 employees, an office in Rochester, and locations in North Dakota, California, and Texas. Last year was a landmark: Preventice landed $137 million in a Series B financing round and posted net sales of $158 million, up 30 percent from 2019.
In January, Preventice agreed to be acquired by Boston Scientific for $925 million. Otterstatter will stay on with the company. Boston Scientific has invested in Preventice since 2015.